The potential expansion of CAR T-cell therapy to more common cancers will lead to a ramping up of patient need that Australia is currently not prepared for, an expert has warned. Speaking during a HSANZ symposium on T-cell therapeutics, Professor Michael Dickinson from the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital said that ...
CAR T-cell demand likely to ramp up in Australia
By Nicola Garrett
21 Oct 2019